Logo image of BKSY

BLACKSKY TECHNOLOGY INC (BKSY) Stock Fundamental Analysis

NYSE:BKSY - New York Stock Exchange, Inc. - US09263B2079 - Common Stock - Currency: USD

10.89  -0.56 (-4.89%)

After market: 10.87 -0.02 (-0.18%)

Fundamental Rating

3

BKSY gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 82 industry peers in the Professional Services industry. BKSY scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. BKSY is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

BKSY had negative earnings in the past year.
BKSY had a positive operating cash flow in the past year.
In the past 5 years BKSY always reported negative net income.
BKSY had a negative operating cash flow in each of the past 5 years.
BKSY Yearly Net Income VS EBIT VS OCF VS FCFBKSY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -50M -100M -150M -200M

1.2 Ratios

Looking at the Return On Assets, with a value of -19.03%, BKSY is doing worse than 82.93% of the companies in the same industry.
With a Return On Equity value of -61.03%, BKSY is not doing good in the industry: 86.59% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -19.03%
ROE -61.03%
ROIC N/A
ROA(3y)-26.08%
ROA(5y)-34.97%
ROE(3y)-59.85%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BKSY Yearly ROA, ROE, ROICBKSY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 300

1.3 Margins

Looking at the Gross Margin, with a value of 69.28%, BKSY belongs to the top of the industry, outperforming 85.37% of the companies in the same industry.
BKSY's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for BKSY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 69.28%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y35.19%
BKSY Yearly Profit, Operating, Gross MarginsBKSY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

4

2. Health

2.1 Basic Checks

BKSY does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BKSY has more shares outstanding
The number of shares outstanding for BKSY has been reduced compared to 5 years ago.
Compared to 1 year ago, BKSY has a worse debt to assets ratio.
BKSY Yearly Shares OutstandingBKSY Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BKSY Yearly Total Debt VS Total AssetsBKSY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

BKSY has an Altman-Z score of -1.98. This is a bad value and indicates that BKSY is not financially healthy and even has some risk of bankruptcy.
BKSY has a Altman-Z score of -1.98. This is amonst the worse of the industry: BKSY underperforms 85.37% of its industry peers.
BKSY has a debt to FCF ratio of 14.74. This is a negative value and a sign of low solvency as BKSY would need 14.74 years to pay back of all of its debts.
BKSY has a Debt to FCF ratio of 14.74. This is in the lower half of the industry: BKSY underperforms 62.20% of its industry peers.
A Debt/Equity ratio of 1.26 is on the high side and indicates that BKSY has dependencies on debt financing.
With a Debt to Equity ratio value of 1.26, BKSY is not doing good in the industry: 80.49% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.26
Debt/FCF 14.74
Altman-Z -1.98
ROIC/WACCN/A
WACC7.84%
BKSY Yearly LT Debt VS Equity VS FCFBKSY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

BKSY has a Current Ratio of 3.79. This indicates that BKSY is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.79, BKSY belongs to the top of the industry, outperforming 92.68% of the companies in the same industry.
BKSY has a Quick Ratio of 3.79. This indicates that BKSY is financially healthy and has no problem in meeting its short term obligations.
BKSY has a better Quick ratio (3.79) than 92.68% of its industry peers.
Industry RankSector Rank
Current Ratio 3.79
Quick Ratio 3.79
BKSY Yearly Current Assets VS Current LiabilitesBKSY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

6

3. Growth

3.1 Past

BKSY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.76%, which is quite good.
BKSY shows a small growth in Revenue. In the last year, the Revenue has grown by 7.04%.
The Revenue has been growing by 49.41% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)10.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)7.04%
Revenue growth 3Y44.14%
Revenue growth 5Y49.41%
Sales Q2Q%21.9%

3.2 Future

Based on estimates for the next years, BKSY will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.83% on average per year.
BKSY is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 26.81% yearly.
EPS Next Y56.15%
EPS Next 2Y32.9%
EPS Next 3Y25.67%
EPS Next 5Y19.83%
Revenue Next Year24.33%
Revenue Next 2Y26.1%
Revenue Next 3Y28.08%
Revenue Next 5Y26.81%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
BKSY Yearly Revenue VS EstimatesBKSY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M 500M
BKSY Yearly EPS VS EstimatesBKSY Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -5 -10 -15

1

4. Valuation

4.1 Price/Earnings Ratio

BKSY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BKSY. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BKSY Price Earnings VS Forward Price EarningsBKSY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, BKSY is valued a bit more expensive than the industry average as 62.20% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 44.05
EV/EBITDA N/A
BKSY Per share dataBKSY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2 3

4.3 Compensation for Growth

BKSY's earnings are expected to grow with 25.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.9%
EPS Next 3Y25.67%

0

5. Dividend

5.1 Amount

No dividends for BKSY!.
Industry RankSector Rank
Dividend Yield N/A

BLACKSKY TECHNOLOGY INC

NYSE:BKSY (6/13/2025, 8:04:01 PM)

After market: 10.87 -0.02 (-0.18%)

10.89

-0.56 (-4.89%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)08-06 2025-08-06/bmo
Inst Owners49.98%
Inst Owner Change8.44%
Ins Owners2.95%
Ins Owner Change6.29%
Market Cap344.67M
Analysts83.08
Price Target17.85 (63.91%)
Short Float %11.94%
Short Ratio3.91
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-104.71%
Min EPS beat(2)-215.64%
Max EPS beat(2)6.22%
EPS beat(4)3
Avg EPS beat(4)-43.63%
Min EPS beat(4)-215.64%
Max EPS beat(4)34.64%
EPS beat(8)5
Avg EPS beat(8)-15.09%
EPS beat(12)8
Avg EPS beat(12)-4.85%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-3.25%
Min Revenue beat(2)-13%
Max Revenue beat(2)6.5%
Revenue beat(4)1
Avg Revenue beat(4)-7.42%
Min Revenue beat(4)-19.54%
Max Revenue beat(4)6.5%
Revenue beat(8)2
Avg Revenue beat(8)-2.26%
Revenue beat(12)2
Avg Revenue beat(12)-3%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.19%
PT rev (3m)0.96%
EPS NQ rev (1m)11.97%
EPS NQ rev (3m)20.16%
EPS NY rev (1m)0%
EPS NY rev (3m)1.11%
Revenue NQ rev (1m)-2.33%
Revenue NQ rev (3m)-7.93%
Revenue NY rev (1m)-0.26%
Revenue NY rev (3m)-1.44%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.21
P/FCF 44.05
P/OCF 13.97
P/B 3.88
P/tB 4.7
EV/EBITDA N/A
EPS(TTM)-2.57
EYN/A
EPS(NY)-0.7
Fwd EYN/A
FCF(TTM)0.25
FCFY2.27%
OCF(TTM)0.78
OCFY7.16%
SpS3.39
BVpS2.81
TBVpS2.32
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -19.03%
ROE -61.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 69.28%
FCFM 7.29%
ROA(3y)-26.08%
ROA(5y)-34.97%
ROE(3y)-59.85%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y35.19%
F-Score5
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 1.26
Debt/FCF 14.74
Debt/EBITDA N/A
Cap/Depr 41.77%
Cap/Sales 15.69%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.79
Quick Ratio 3.79
Altman-Z -1.98
F-Score5
WACC7.84%
ROIC/WACCN/A
Cap/Depr(3y)34.25%
Cap/Depr(5y)22.9%
Cap/Sales(3y)16.46%
Cap/Sales(5y)10.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y56.15%
EPS Next 2Y32.9%
EPS Next 3Y25.67%
EPS Next 5Y19.83%
Revenue 1Y (TTM)7.04%
Revenue growth 3Y44.14%
Revenue growth 5Y49.41%
Sales Q2Q%21.9%
Revenue Next Year24.33%
Revenue Next 2Y26.1%
Revenue Next 3Y28.08%
Revenue Next 5Y26.81%
EBIT growth 1Y17.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year140.21%
EBIT Next 3Y56.71%
EBIT Next 5Y39.32%
FCF growth 1Y112.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y150.99%
OCF growth 3YN/A
OCF growth 5YN/A